Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
Department of Neurosurgery,St Vincent's Hospital, Sydney, New South Wales, Australia.
Stereotact Funct Neurosurg. 2022;100(5-6):321-330. doi: 10.1159/000526072. Epub 2022 Sep 12.
Cerebral palsy (CP) is a common cause of acquired dystonia, which can lead to significant interference with quality of life and societal participation. In the last two decades, the surgical treatment of dystonia has primarily focused on deep brain stimulation targeting the basal ganglia and thalamic circuits. However, stimulation of the basal ganglia has generally been less effective in acquired combined forms of dystonia, including dystonic CP. These limitations, along with growing evidence for the role of the cerebellum in the pathophysiology of dystonia, have led to renewed interest in the cerebellum as a target for therapeutic stimulation in dystonia. Nevertheless, there are very few contemporary studies demonstrating its use. We present the case of a patient with generalized dystonia due to dyskinetic CP who was successfully treated with stimulation of the cerebellar cortex in the modern era. We also review the evidence underpinning targeting of the cerebellum in surgical therapy for dystonia and examine the latest reports of this approach in the surgical literature.
The patient derived significant improvement in the control of her dystonic symptoms, with a reduction in her BFMDRS score from 83 to 25. No complications were observed during more than 3 years of postoperative follow-up. Since the turn of the 21st century, there have been only 7 reports of cerebellar stimulation for dystonia, recruiting a total of 18 patients. These studies have exclusively targeted deep brain structures, making the present report of cortical cerebellar stimulation particularly unique.
In the 21st century, cerebellar stimulation has predominantly been a second-line treatment for dystonia, after the failure of DBS targeting more mainstream loci within the thalamus and globus pallidus. However, there is increasing recognition of the role of the cerebellum in movement disorders, with multiple convergent lines of evidence supporting its involvement in dystonia pathophysiology. The cerebellum is worthy of greater consideration as a target for neurostimulation in dystonia, particularly in cases of acquired etiology.
脑瘫(CP)是获得性肌张力障碍的常见原因,可导致生活质量和社会参与度受到严重干扰。在过去的二十年中,肌张力障碍的手术治疗主要集中在针对基底节和丘脑回路的深部脑刺激。然而,基底节刺激在包括肌张力障碍性 CP 在内的获得性混合形式的肌张力障碍中通常效果较差。这些局限性,以及小脑在肌张力障碍病理生理学中的作用的不断增加的证据,导致人们对小脑作为治疗性刺激靶点在肌张力障碍中的作用重新产生兴趣。尽管如此,很少有当代研究证明其使用。我们报告了一例由运动障碍性 CP 引起的全身性肌张力障碍患者的病例,该患者在现代接受小脑皮质刺激治疗后获得成功。我们还回顾了在肌张力障碍手术治疗中靶向小脑的证据,并研究了该方法在手术文献中的最新报告。
患者的肌张力障碍症状得到了明显改善,BFMDRS 评分从 83 分降至 25 分。在超过 3 年的术后随访中,没有观察到任何并发症。自 21 世纪初以来,只有 7 篇关于小脑刺激治疗肌张力障碍的报告,共招募了 18 名患者。这些研究仅靶向深部脑结构,因此本报告的皮质小脑刺激尤其独特。
在 21 世纪,小脑刺激主要是深部脑刺激(DBS)靶向丘脑和苍白球等主流核团失败后的二线治疗方法。然而,越来越多的人认识到小脑在运动障碍中的作用,越来越多的证据支持小脑在肌张力障碍病理生理学中的作用。小脑作为肌张力障碍神经刺激的靶点值得进一步考虑,特别是在获得性病因的情况下。